Patent ID: 8623879

Claim:
A compound according to general formula I, wherein Hc is selected from the group of tetrahydropyranyl, tetrahydrofuranyl, piperidinyl and pyrrolidinyl; R 1 is selected from the group of phenyl, 2-, 3- and 4-pyridyl-, pyrimidinyl, pyrazolyl, thiazolyl, cyclopropyl, cyclobutyl, cyclopentyl, cycloheptyl, cyclopentylmethyl, cyclohexyl, ethyl, 1- and 2-propyl, 1- and 2-butyl-, 1-, 2- and 3-pentyl-, tetrahydrofuranyl and tetrahydropyranyl, where these R 1 groups may optionally be substituted by one or more substituents independently of one another selected from the group consisting of fluorine, chlorine, bromine, iodine, HO—, oxo, NC—, C 1-6 -alkyl-O—, C 1-6 -alkyl-, C 3-7 -cycloalkyl-O—,C 3-7 cycloalkyl-C 1-3 alkyl-O—,CF 3 O— and CF 3 ; R 2 independently of any other R 2 is selected from the group of H—, C 1-6 -alkyl- and oxo, and in cases wherein R 2 is attached to a nitrogen which is a ring member of Hc, this R 2 shall be independently of any other R 2 selected from: H—, C 1-6 -alkyl-CO—, C 1-6 -alkyl-O—CO—, C 1-6 -alkyl-, phenyl-CO—, phenyl-O—CO—and (C 1-6 -alkyl) 2 N—CO—, where the above-mentioned R 2 members may optionally be substituted independently of one another by one or more fluorine substituents; R 3 is selected from the group of H—, hydroxy and C 1-6 -alkyl-O—, whereby C 1-6 -alkyl-O— may optionally be substituted by one or more fluorine, chlorine, bromine and HO—; R 4 and R 5 independently of one another are selected from the group of H—, fluorine, and methyl; x is 0, 1, 2, 3 or 4; y is 0 or 1; or a pharmaceutically acceptable salt, a tautomer or a stereoisomer thereof.